Viewing Study NCT00524433

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-03-04 @ 12:44 AM
Study NCT ID: NCT00524433
Status: COMPLETED
Last Update Posted: 2018-07-10
First Post: 2007-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Tezosentan in the Treatment of Acute Heart Failure
Sponsor: Idorsia Pharmaceuticals Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Heart Failure View
None Acute Decompensation of Chronic Heart Failure View
None New Onset of Heart Failure View
Keywords:

Keywords

Keyword Brief Keyword Text View
None acute heart failure View
None acute decompensation of chronic heart failure View
None new onset of heart failure View
None tezosentan View
None Actelion View